Advertisement

Marlborough medical device company CardioFocus Inc. has landed the anticipated $5 million credit facility from Silicon Valley Bank, which the company says it will use to start a U.S. trial of its Endoscopic Ablation System in heart surgery.

In February, CardioFocus CEO Stephen Sagon mentioned the planned credit line in an interview about the company’s latest venture capital round, in which it raised $13.64 million of a planned $15.64 million. 

SOURCE

Advertisement
Advertisement